Degranulation is enhanced in mast cells lacking the enzyme that reduces 7-dehydrocholesterol (DHCR KO).
Patients with SLOS have abnormally low levels of circulating cholesterol—and a corresponding abundance of the cholesterol precursor 7-dehydrocholesterol (DHC)—due to defects in the gene that encodes the DHC-reducing enzyme (DHCR7). This cholesterol deficiency causes a bevy of developmental defects, consistent with the known requirement for cholesterol during embryonic development.
But the allergic manifestations of SLOS are poorly understood. Kovarova and colleagues suspected that mast cells—the principle allergy-triggering cell type—might be involved, as mast cells rely on the proper distribution of cholesterol-rich lipid rafts in their...